ngµç×ÓÓÎÏ·

05

¿ÆÑÐÏ£Íû

¿ïÃú¡¢ÁÖË®±öÍŶÓÏàÖú½ÒÏþ¸ÎÄÚµ¨¹Üϸ°û°©Ñо¿Ð§¹û

¸å¼þȪԴ£º£º£ºÁ¥ÊôµÚÒ»Ò½Ôº ±à¼­£º£º£ºÀîͯÖÛ¡¢Íõ¶¬Ã· ÉóºË£º£º£ºÖª×ã ÔĶÁÁ¿£º£º£º

ngµç×ÓÓÎÏ·ÐÂÎÅÍøÑ¶£¨Í¨Ñ¶Ô±Áõº£Äþ£©¿ËÈÕ £¬£¬£¬ngµç×ÓÓÎÏ·Á¥ÊôµÚÒ»Ò½Ôº¸Îµ¨ÒÈÍâ¿ÆÖÐÐÄ¿ïÃú½ÌÊÚÍŶÓÓ뾫׼ҽѧÑо¿ÔºÁÖË®±ö½ÌÊÚÍŶӵÄÏàÖúÑо¿Ð§¹û¡°Targeting tumor-intrinsic N7-methylguanosine tRNA modification inhibits MDSC recruitment and improves anti-PD-1 efficacy¡±½ÒÏþÓÚÓ¢¹ú賦²¡Ñ§»á»á¿¯¡¢Î¸³¦ÁìÓò¶¥¼¶ÆÚ¿¯GutÔÓÖ¾£¨IF=31.79£© £¬£¬£¬¸ÃÑо¿ÆÊÎöÁ˸ÎÄÚµ¨¹Ü°©£¨ICC£©Î¢ÇéÐÎÖжàºËÐÍËèÔ´ÒÖÖÆÐÔϸ°û£¨PMN-MDSC£©ÕÙļµÄ·Ö×Óµ÷¿Ø»úÖÆ £¬£¬£¬Îª¸ÄÉÆICC¿¹PD-1ÄÍÒ©ÌṩÁËÁªºÏÖÎÁÆÐÂÕ½ÂÔ¡£¡£¡£


0CF8A8D8DEB96230030C82E29FF_D30969E3_9344

ͼƬ˵Ã÷£º£º£º¸ÎÄÚµ¨¹Ü°©METTL1Ôö½øCXCL8/Cxcl5µÄ·­ÒëÒÔÕÐļPMN-MDSC £¬£¬£¬½ø¶øÒÖÖÆCD4+Tϸ°ûµÄÀ©ÔöºÍCD4+ºÍCD8+Tϸ°ûµÄ¿¹Ö×Áö»îÐÔ £¬£¬£¬½éµ¼ICC¿¹PD-1ÄÍÒ©¡£¡£¡£°ÐÏòMETTL1²¢×è¶ÏCXCR2ÒÖÖÆPMN-MDSCµÄǨáã £¬£¬£¬»Ö¸´CD4+ºÍCD8+Tϸ°ûµÄ¿¹Ö×Áö¹¦Ð§ £¬£¬£¬¸ÄÉÆICC¿¹PD-1ÖÎÁÆÁÆÐ§¡£¡£¡£


78%µÄICC»¼ÕßÔÚÊ×´ÎÕï¶Ïʱ¼´ÎªÍíÆÚ £¬£¬£¬ÖÎÁÆÊÖ¶ÎÓÐÏÞ¡£¡£¡£ÃâÒß¼ì²éµãÒÖÖÆ¼Á¿ª·¢ÁËÍíÆÚÖ×ÁöÖÎÁƵÄÐÂģʽ £¬£¬£¬µ«ICC¶ÔÃâÒß¼ì²éµãÒÖÖÆ¼ÁµÄÓ¦´ðÂÊÏÔ×ŵÍÓÚÆäËûʵÌåÖ×Áö £¬£¬£¬ÆäDZÔÚ»úÖÆÉв»ÇåÎú¡£¡£¡£

ÃâÒß΢ÇéÐÎÓëÖ×ÁöµÄÏ£ÍûÒÔ¼°ÃâÒßÖÎÁƵÄÏìÓ¦Ç×½üÏà¹Ø £¬£¬£¬¿ïÃú½ÌÊÚÍŶӺÍÁÖË®±ö½ÌÊÚÍŶӻùÓÚngµç×ÓÓÎÏ·Á¥ÊôµÚÒ»Ò½Ôº¸Î°©±ê±¾¿â £¬£¬£¬·¢Ã÷ÍíÆÚµ¨¹Ü°©ÖÐPMN-MDSC½þÈóÏÔÖøÔöÌí £¬£¬£¬ÇÒtRNA m7GÐÞÊÎøMETTL1ÓëPMN-MDSCµÄ½þÈóÇ×½üÏà¹Ø¡£¡£¡£»ùÒò¹¤³ÌÊóµÈ¶àÖÖÌåÄÚÄ£×ÓÕ¹ÏÖMETTL1ͨ¹ýÔö½øÖ×ÁöPMN-MDSCµÄÕÙļ £¬£¬£¬Ôö½øICCÏ£Íû¡£¡£¡£Í¨¹ýtRNA»¹Ô­ºÍ¼ôÇвâÐò¡¢¶à¾ÛºËÌÇÌåÏà¹ØµÄmRNA²âÐò £¬£¬£¬ÍŶӽøÒ»²½·¢Ã÷METTL1Ñ¡ÔñÐÔµ÷¿ØÇ÷»¯Òò×ÓÈËCXCL8ºÍCxcl5µÄ·­Òë £¬£¬£¬×è¶ÏÇ÷»¯Òò×ÓÊÜÌå»òÇóýMETTL1¿ÉÏÔÖø¸ÄÉÆICC¿¹PD-1ÖÎÁƵÄЧ¹û¡£¡£¡£

¸ÃÂÛÎĵÚÒ»×÷ÕßÊÇngµç×ÓÓÎÏ·Á¥ÊôµÚÒ»Ò½Ôº¸Îµ¨ÒÈÍâ¿ÆÖÐÐÄ¿ïÃú½ÌÊÚµÄÔÚ¶Á²©Ê¿ÉúÁõº£Äþ¡¢²©Ê¿ºóÔøÑ©ÕêºÍÔÚ¶Á²©Ê¿ÉúÈÎÐñöΡ£¡£¡£¿£¿ïÃú½ÌÊÚºÍÁÖË®±ö½ÌÊÚΪÅäºÏͨѶ×÷Õß¡£¡£¡£¿£¿ïÃú½ÌÊÚÓëÁÖË®±ö½ÌÊÚºã¾ÃÏàÖú̽Ìָΰ©mRNAµÄÒì³£·­Òëµ÷¿Ø×÷Óà £¬£¬£¬¼ÈÍùÑо¿Ð§¹ûÕ¹ÏÖÁËmRNAÒì³£·­Òë¶Ô¸Î°©±¬·¢¿ªÕ¹µÄÒªº¦×÷Óò¢ÓÚMolecular CellµÈÔÓÖ¾½ÒÏþ¶àƪÏàÖúÂÛÎÄ¡£¡£¡£ÏÖ´ÓÃâÒßÐÂÊÓ½ÇÊ×´ÎÕ¹ÏÖÇ÷»¯Òò×ÓÔÚmRNA·­Òë²ãÃæ±»Òì³£µ÷¿ØµÄлúÖÆ £¬£¬£¬Îª¸ÄÉÆICC¿¹PD-1ÖÎÁÆÁÆÐ§ÌṩÁªºÏÐÂÕ½ÂÔ¡£¡£¡£

ÂÛÎÄÁ´½Ó£º£º£ºhttps://gut.bmj.com/content/early/2022/10/25/gutjnl-2022-327230


¡¾ÍøÕ¾µØÍ¼¡¿